drugset / Trial / NCT04983043

Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

NCT04983043

Phase 2 Completed 228 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety and the best effective dose of QiShen YiQi Dripping Pills in the treatment of chronic heart failure with decreased ejection fraction of CHD (Qi deficiency and blood stasis syndrome).

Timeline

Start
2021-06-10
Primary completion
2024-11-27
Completion
2024-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 1.04 g Oral
Subject Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 1.56 g Oral